| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $380.8M | +1612.9% |
| Cost of Revenue | $25.4M | +750.0% |
| R&D Expense | $128.2M | +37.2% |
| SG&A Expense | $188.4M | +48.2% |
| Operating Income | $38.8M | +119.3% |
| Pre-tax Income | $54.3M | +127.5% |
| Income Tax | $5.0M | +549.4% |
| Net Income | $49.3M | +124.8% |
| EPS (Basic) | $0.73 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $170.2M | +172.2% |
| Short-term Investments | $201.2M | -29.3% |
| Accounts Receivable | $40.0M | +161.7% |
| Inventory | $38.3M | +292.3% |
| Current Assets | $464.7M | +21.6% |
| Total Assets | $517.5M | +32.2% |
| Current Liabilities | $82.0M | +76.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.9M | +106.6% |
| Capital Expenditures | $1.2M | -50.9% |
| Investing Cash Flow | $92.1M | +138.5% |
| Financing Cash Flow | $3.5M | -99.2% |
| Free Cash Flow | $10.7M | +105.9% |
| +121.5% |
| EPS (Diluted) | $0.70 | +120.6% |
| Total Liabilities |
| $84.0M |
| +65.2% |
| Stockholders' Equity | $433.4M | +27.3% |